The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Nefedova N.A.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova"

Kharlova O.A.

Russian Medical Academy of Postgraduate Education, Moscow

Mal'kov P.G.

GUNU "Fakul'tet fundamental'noĭ meditsiny MGU im. M.V. Lomonosova";
GBOU DPO "Rossiĭskaia meditsinskaia akademiia poslediplomnogo obrazovaniia", Moskva

Еxpression of claudin-1, 3, and 4 in colorectal cancer and polyps

Authors:

Nefedova N.A., Kharlova O.A., Mal'kov P.G.

More about the authors

Read: 2291 times


To cite this article:

Nefedova NA, Kharlova OA, Mal'kov PG. Еxpression of claudin-1, 3, and 4 in colorectal cancer and polyps. Russian Journal of Archive of Pathology. 2016;78(3):11‑19. (In Russ.)
https://doi.org/10.17116/patol201678311-19

Recommended articles:
Soli­tary fibrous tumor of the kidney. Russian Journal of Archive of Pathology. 2025;(3):77-81
Prognostically unfa­vorable types of breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(6):78-82
Onco­cytic thyroid adenoma imitating functionally active para­thyroid adenoma. Piro­gov Russian Journal of Surgery. 2025;(12):156-161

References:

  1. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 2000;19(9):2024-2033. doi:10.1093/emboj/19.9.2024.
  2. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfeld DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis. 1999;20(8):1425-1431. doi:10.1093/carcin/20.8.1425.
  3. Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am J Respir Cell Mol Biol. 2004;30(6):761-770.  doi:10.1165/rcmb.2003-0370OC.
  4. Rangel LB, Agarwal R, D'Souza T, Pizer ES, Alò PL, Lancaster WD et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res. 2003;9(7):2567-2575. Available at: http://clincancerres.aacrjournals.org/content/9/7/2567.long.
  5. Sheehan GM, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Ross JS. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol. 2007;38:564-569.  doi:10.1016/j.humpath.2006.11.007.
  6. Holczbauer Á, Gyöngyösi B, Lotz G, Szijártó A, Kupcsulik P, Schaff Z, Kiss A. Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas. J Histochem Cytochem. 2013;61(4):294-305.  doi:10.1369/0022155413479123.
  7. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C et al. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115(7):1765-1776. doi:10.1172/jci24543.
  8. Matsuoka T, Mitomi H, Fukui N, Kanazawa H, Saito T, Hayashi T, Yao T. Cluster analysis of claudin-1 and -4, E-cadherin, and beta-catenin expression in colorectal cancers. J Surg Oncol. 2011;103(7):674-686.  doi:10.1002/jso.21854.
  9. Süren D, Yıldırım M, Kaya V, Alikanoğlu AS, Bülbüller N, Yıldız M, Sezer C. Loss of tight junction proteins (Claudin 1, 4, and 7) correlates with aggressive behavior in colorectal carcinoma. Med Sci Monit. 2014;20:1255-1262. doi:10.12659/msm.890598.
  10. Takehara M, Nishimura T, Mima S, Hoshino T, Mizushima T. Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull. 2009;32(5):825-831.  doi:10.1248/bpb.32.825.
  11. Snover D, Ahnen DJ, Burt RW, Odze RD et al. Serrated polyps of the colon and rectum and serrated («hyperplastic») polyposis. In: Bozman FT, Carneiro F, Hruban RH, Thiese ND, eds. WHO Classification of tumours pathology and genetics tumours of the digestive system. 4th ed. Lyon: IARC Press; 2010:160-165.
  12. Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E. Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype. Mod Pathol. 2013;26(4):485-95.  doi:10.1038/modpathol.2012.187.
  13. Shibutani M, Noda E, Maeda K, Nagahara H, Ohtani H, Hirakawa K. Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer. Anticancer Res. 2013;33(8):3301-6. Available et: http://www.ncbi.nlm.nih.gov/pubmed/?term=23898096.
  14. Yoshida T, Kinugasa T, Akagi Y, Kawahara A, Romeo K, Shiratsuchi I et al. Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosis. Anticancer Res. 2011;31(7):2517-2525. Available at: http://ar.iiarjournals.org/content/31/7/2517.long.
  15. Abdelzaher E, Rizk AM, Bessa SS, Omer KM. Predictive value of immunohistochemical expression of claudin-1 in colonic carcinoma. J Egypt Natl Canc Inst. 2011;23(4):123-131.  doi:10.1016/j.jnci.2011.10.002.
  16. Nakagawa S, Miyoshi N, Ishii H, Mimori K, Tanaka F, Sekimoto M et al. Expression of CLDN1 in colorectal cancer: a novel marker for prognosis. Int J Oncol. 2011;39(4):791-796.  doi:10.3892/ijo.2011.1102.
  17. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y, Furukawa Y. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res. 2001;12(11-12):469-476.  doi:10.3727/096504001108747477.
  18. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005;65(16):7378-7385. doi:10.1158/0008-5472.can-05-1036.
  19. Bettington ML, Walker NI, Rosty C, Brown IS, Clouston AD, McKeone DM et al. A clinicopathological and molecular analysis of 200 traditional serrated adenomas. Mod Pathol. 2015;28(3):414-427.  doi:10.1038/modpathol.2014.122.
  20. Langner C. Serrated and non-serrated precursor lesions of colorectal cancer. Dig Dis. 2015;3:28-37.  doi:10.1159/000366032.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.